Société canadienne de la rétine

Maladie maculaire

Le jeudi 28 juin 2012, 1545-1715
Harbour C

Objectifs
À la fin de la session, les participants pourront :

  • Discuter de la gestion des maladies maculaires.


Invités
Harry W. Flynn, Jr. MD
Yale L. Fisher, MD
Animateur
John Chen

1545Intravitreal injections and infection
Harry W. Flynn
1600Discussion
1605Intraocular foreign body management
Yale L. Fisher
1620Discussion
1625A novel pre-clinical model mimics the clinical features of reticular drusen disease (RDD) and the junctional zone of advancing non-exudative age-related macular degeneration (AMD)
Roxane Hillier, Xu Zhao, Hai Wang, Natalie Pankova, Shelley Boyd
1630Discussion
1632Intravitreal lucentis for the treatment of AMD related pigment epithelial detachment
Yiannis Iordanous, AnneMarie Powell, Alexander Mao, Philip L. Hooper, Carol Schwartz, Peter Kertes, Thomas Sheidow
1637Discussion
1639Choroidal neovascular membrane recurrence rate in wet AMD patients stable on three month ranibizumab dosing
Mark A. Mandell, Michael H. Brent
1644Discussion
1646Should paracenthesis be performed after intraocular Anti-VEGF injection?
Rani N. Al Karmi
1651Discussion
1653The effect of repeated topical fluoroquinolone use post intravitreal injection for neovascular Age-related Macular Degeneration (AMD) on ocular surface flora
Vivian Yin, Daniel Weisbord, Ken Eng, Efrem Mandelcorn, Radha Kohly, Carol Schwartz, Wai-Ching Lam, Andrew Simor, Peter Kertes
1655Bacterial endophthalmitis: a ten-year review of the culture and sensitivity patterns of bacterial isolates
David Assaad, David Wong, Mikel Mikhail, Filiberto Altomare, Alan Berger, David Chow, Louis Giavedoni
1700Discussion
1702The use of OCT and autofluorescence in the diagnosis of early anti-malarial maculopathy
Michael Easterbrook, Michael H. Brent
1707Discussion


Harry W. Flynn Jr, MD


Yale L. Fisher, MD